Shifamed

Shifamed company information, Employees & Contact Information

Explore related pages

Related company profiles:

Shifamed is a highly specialized innovation hub, striving to resolve unmet needs in the medtech industry. We are a multi-disciplined group of engineers with the imagination, ambition, and experience to identify and capitalize on emerging opportunities through rapid tactical execution. With an emphasis on advanced technology and collaboration, we are dedicated to finding better ways to address critical healthcare needs. History demonstrates our ability to design, develop, and commercialize products that are done right and enhance clinical outcomes. Learn more at shifamed.com

Company Details

Employees
90
Founded
-
Address
590 Division St, Campbell,california 95008,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Campbell, California
Looking for a particular Shifamed employee's phone or email?

Shifamed Questions

News

Poised for Growth, Enlil, a Shifamed Portfolio Company, Appoints Nader Fathi as Chief Executive Officer - PR Newswire

Poised for Growth, Enlil, a Shifamed Portfolio Company, Appoints Nader Fathi as Chief Executive Officer PR Newswire

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma - Morningstar

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma Morningstar

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States - PR Newswire

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States PR Newswire

Enlil's Purpose-Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem - PR Newswire

Enlil's Purpose-Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem PR Newswire

FDA says Shifamed’s Myra Vision can begin glaucoma implant study - MassDevice

FDA says Shifamed’s Myra Vision can begin glaucoma implant study MassDevice

FIRST PATIENT ENROLLED IN AKURA MEDICAL'S US PIVOTAL TRIAL FOR PULMONARY EMBOLISM - PR Newswire

FIRST PATIENT ENROLLED IN AKURA MEDICAL'S US PIVOTAL TRIAL FOR PULMONARY EMBOLISM PR Newswire

AKURA MEDICAL SECURES FDA APPROVAL FOR US PIVOTAL TRIAL IN PULMONARY EMBOLISM - PR Newswire

AKURA MEDICAL SECURES FDA APPROVAL FOR US PIVOTAL TRIAL IN PULMONARY EMBOLISM PR Newswire

Adona Medical, a Shifamed Portfolio Company, Raises $33.5 Million in Series C Financing - PR Newswire

Adona Medical, a Shifamed Portfolio Company, Raises $33.5 Million in Series C Financing PR Newswire

TIOGA CARDIOVASCULAR ANNOUNCES FIRST-IN-HUMAN CASES WITH ITS LUNA™ TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) SYSTEM - PR Newswire

TIOGA CARDIOVASCULAR ANNOUNCES FIRST-IN-HUMAN CASES WITH ITS LUNA™ TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR) SYSTEM PR Newswire

Akura Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing - PR Newswire

Akura Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing PR Newswire

Akura Medical, A Shifamed Portfolio Company, Appoints Murali Srivathsa as President and CEO - PR Newswire

Akura Medical, A Shifamed Portfolio Company, Appoints Murali Srivathsa as President and CEO PR Newswire

SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION AS THE COMPANY CLOSED $40M IN SERIES D FINANCING - PR Newswire

SUPIRA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION AS THE COMPANY CLOSED $40M IN SERIES D FINANCING PR Newswire

ADONA MEDICAL, A SHIFAMED PORTFOLIO COMPANY, SECURES $37.5M IN SERIES B FINANCING - PR Newswire

ADONA MEDICAL, A SHIFAMED PORTFOLIO COMPANY, SECURES $37.5M IN SERIES B FINANCING PR Newswire

SUPIRA MEDICAL INITIATES U.S. EARLY FEASIBILITY STUDY (EFS) FOR HIGH-RISK PCI - PR Newswire

SUPIRA MEDICAL INITIATES U.S. EARLY FEASIBILITY STUDY (EFS) FOR HIGH-RISK PCI PR Newswire

ATIA VISION, A SHIFAMED PORTFOLIO COMPANY, TO CLOSE ON $42M SERIES E FINANCING - PR Newswire

ATIA VISION, A SHIFAMED PORTFOLIO COMPANY, TO CLOSE ON $42M SERIES E FINANCING PR Newswire

ADONA MEDICAL INITIATES FIRST-IN-HUMAN STUDY WITH ITS NOVEL INTERATRIAL SHUNT FOR PATIENTS WITH HEART FAILURE - PR Newswire

ADONA MEDICAL INITIATES FIRST-IN-HUMAN STUDY WITH ITS NOVEL INTERATRIAL SHUNT FOR PATIENTS WITH HEART FAILURE PR Newswire

ADONA MEDICAL COMPLETES ENROLLMENT IN FIRST-IN-HUMAN TRIAL FOR NOVEL INTERATRIAL SHUNT FOR PATIENTS WITH HEART FAILURE - PR Newswire

ADONA MEDICAL COMPLETES ENROLLMENT IN FIRST-IN-HUMAN TRIAL FOR NOVEL INTERATRIAL SHUNT FOR PATIENTS WITH HEART FAILURE PR Newswire

TIOGA CARDIOVASCULAR, A SHIFAMED PORTFOLIO COMPANY, CLOSES $30M IN SERIES C FINANCING - PR Newswire

TIOGA CARDIOVASCULAR, A SHIFAMED PORTFOLIO COMPANY, CLOSES $30M IN SERIES C FINANCING PR Newswire

Shifamed Announces Successful Acquisition Of Nuvera Medical, The Sixth Company To Exit Associated With The Innovation Hub - PR Newswire

Shifamed Announces Successful Acquisition Of Nuvera Medical, The Sixth Company To Exit Associated With The Innovation Hub PR Newswire

SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT GENERATION PERCUTANEOUS VENTRICULAR ASSIST DEVICE - PR Newswire

SUPIRA MEDICAL ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS NEXT GENERATION PERCUTANEOUS VENTRICULAR ASSIST DEVICE PR Newswire

Shifamed’s Laza Medical closes $36M Series A to support cardiac imaging tech - MassDevice

Shifamed’s Laza Medical closes $36M Series A to support cardiac imaging tech MassDevice

Laza Medical Closes $36 Million in Series A - The SaaS News

Laza Medical Closes $36 Million in Series A The SaaS News

Shifamed’s Adona Medical raises $33.5M - MassDevice

Shifamed’s Adona Medical raises $33.5M MassDevice

LAZA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, CLOSES $36M IN SERIES A FINANCING - PR Newswire

LAZA MEDICAL, INC., A SHIFAMED PORTFOLIO COMPANY, CLOSES $36M IN SERIES A FINANCING PR Newswire

Tioga Medical, A Shifamed Portfolio Company, Closes $30M In Series B Financing - PR Newswire

Tioga Medical, A Shifamed Portfolio Company, Closes $30M In Series B Financing PR Newswire

Shifamed’s Akura Medical raises $35M for thrombectomy system - MassDevice

Shifamed’s Akura Medical raises $35M for thrombectomy system MassDevice

New imaging vendor focused on AI, robotics raises $36M with help from GE Healthcare - Cardiovascular Business

New imaging vendor focused on AI, robotics raises $36M with help from GE Healthcare Cardiovascular Business

Myra Vision initiates FIH trial on Calibreye System for IOP reduction - Eyes On Eyecare

Myra Vision initiates FIH trial on Calibreye System for IOP reduction Eyes On Eyecare

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings - PR Newswire

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings PR Newswire

DR. AZEEM LATIB, WORLD-RENOWNED INTERVENTIONAL CARDIOLOGIST, TO JOIN THE LEADERSHIP TEAM OF SUPIRA MEDICAL - PR Newswire

DR. AZEEM LATIB, WORLD-RENOWNED INTERVENTIONAL CARDIOLOGIST, TO JOIN THE LEADERSHIP TEAM OF SUPIRA MEDICAL PR Newswire

Myra Vision Announces Positive Initial Outcomes from its Feasibility Study at the 2025 American Glaucoma Society Meeting - PR Newswire

Myra Vision Announces Positive Initial Outcomes from its Feasibility Study at the 2025 American Glaucoma Society Meeting PR Newswire

Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement - MassDevice

Shifamed’s Tioga Cardiovascular has first human cases with mitral valve replacement MassDevice

Atia Vision Announces Presentation of First-In-Human Results with Their Novel Intraocular Lens at American Society of Cataract Refractive Surgery (ASCRS) Annual Meeting - PR Newswire

Atia Vision Announces Presentation of First-In-Human Results with Their Novel Intraocular Lens at American Society of Cataract Refractive Surgery (ASCRS) Annual Meeting PR Newswire

FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu™ Lens System in Patients with Cataracts - BioSpace

FDA Grants Atia Vision Approval to Begin US Clinical Trial of OmniVu™ Lens System in Patients with Cataracts BioSpace

NuVera Announces Successful First-in-Human Use of NuVision™ ICE Catheter - PR Newswire

NuVera Announces Successful First-in-Human Use of NuVision™ ICE Catheter PR Newswire

Atia Vision closes $20m Series D - MassDevice

Atia Vision closes $20m Series D MassDevice

Top Shifamed Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant